Semaglutide - 30mg

Semaglutide – GLP-1

Overview:
Semaglutide is a synthetic research peptide that functions as a glucagon-like peptide-1 (GLP-1) receptor agonist. It has been widely studied in preclinical models for its role in modulating insulin secretion, regulating glucose metabolism, and influencing appetite signaling in the central nervous system.

Its receptor selectivity and extended half-life make Semaglutide a useful compound in in-vitro models investigating metabolic and endocrine pathways related to type 2 diabetes and obesity.

Chemical Information
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: 4,113.58 g/mol
Form: Lyophilized Powder
Purity: ≥99%
Storage: Store in a cool, dry place at -20°C. Protect from light.

Key Benefits (Research Use Only):

• Supports studies related to glucose and insulin regulation
• May aid in the exploration of appetite and satiety mechanisms
• Useful in models simulating metabolic disorders and weight regulation
• Ideal for endocrine and GLP-1 receptor pathway analysis

Research Applications
Semaglutide is commonly used in in-vitro models involving:

• Glucose metabolism and insulin signaling
• Appetite regulation and neuroendocrine pathways
• Energy balance and food intake suppression
• GLP-1 receptor pharmacology and response profiling

Product Usage & Compliance Notice
This compound is intended strictly for laboratory research purposes only. It is not a drug, food, or cosmetic, and is not for human or veterinary use. Any bodily introduction is strictly prohibited by law.

Product may only be handled by qualified professionals.
All product content is provided for educational and scientific reference only.
Do not misbrand, misuse, or misrepresent this product.

Patent & Trademark Notice
Semaglutide is a patented compound developed by Novo Nordisk and may be marketed under the brand names Ozempic® or Wegovy®. Any mention of Semaglutide on this site is strictly for informational purposes regarding its availability as a research compound. This product is not manufactured, endorsed, or approved by Novo Nordisk.